{"url_path":"/sec/ahr/8-k/2026-06-25/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-25","source_url":"https://www.sec.gov/Archives/edgar/data/1632970/0001193125-26-282860-index.html","accession_number":"0001193125-26-282860","cik":"0001632970","ticker":"AHR","issuer_name":"American Healthcare REIT, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1632970/0001193125-26-282860-index.html","primary_entity_key":"0001632970","primary_entity_name":"American Healthcare REIT, Inc."},"word_count":460,"has_tables":true,"body_markdown":"## Item 5.07 Submission of Matters to a Vote of Security Holders.\n\n## On June 24, 2026, we held our 2026 Annual Meeting of Stockholders. At the meeting, our stockholders voted on the following three proposals: (i) to consider and vote upon the election of nine directors, each to hold office for a one-year term expiring at the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualifies; (ii) to consider and vote upon the ratification of the appointment of Deloitte & Touche LLP, or Deloitte & Touche, as our independent registered public accounting firm for the year ending December 31, 2026; and (iii) to approve, on an advisory (non-binding) basis, the compensation paid to our named executive officers for the year ended December 31, 2025. The three proposals are described in detail in our definitive proxy statement, dated April 9, 2026, as filed with the United States Securities and Exchange Commission on Schedule 14A on April 9, 2026.\n\n##  \n\n## The votes with respect to each of the proposals are set forth below.\n\n## Proposal 1. To consider and vote upon the election of nine directors, each to hold office for a one-year term expiring at the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualifies:\n\nNominee\n\nShares For\n\nShares Withheld\n\nBroker Non-Votes\n\n \n\n \n\n \n\n \n\nJeffrey T. Hanson\n\n150,602,098\n\n6,878,465\n\n16,097,079\n\nDanny Prosky\n\n156,485,882\n\n994,681\n\n16,097,079\n\nMathieu B. Streiff\n\n99,168,560\n\n58,312,003\n\n16,097,079\n\nScott A. Estes\n\n156,000,737\n\n1,479,826\n\n16,097,079\n\nBrian J. Flornes\n\n131,491,865\n\n25,988,698\n\n16,097,079\n\nDianne Hurley\n\n155,666,956\n\n1,813,607\n\n16,097,079\n\nMarvin R. O'Quinn\n\n156,630,288\n\n850,275\n\n16,097,079\n\nValerie Richardson\n\n148,465,492\n\n9,015,071\n\n16,097,079\n\nWilbur H. Smith III\n\n147,262,301\n\n10,218,262\n\n16,097,079\n\n \n\nThe nine above-referenced nominees therefore were elected as our directors by the requisite vote of our stockholders necessary for approval.\n\n \n\nProposal 2. To consider and vote upon the ratification of the appointment of Deloitte & Touche as our independent registered public accounting firm for the year ending December 31, 2026:\n\n \n\nShares For\n\nShares Against\n\nShares Abstained\n\n \n\n \n\n \n\n172,002,161\n\n1,383,331\n\n192,150\n\n \n\nProposal 3. To approve, on an advisory (non-binding) basis, the compensation paid to our named executive officers for the year ended December 31, 2025:\n\n \n\nShares For\n\nShares Against\n\nShares Abstained\n\nBroker Non-Votes\n\n \n\n \n\n \n\n \n\n152,134,858\n\n5,019,014\n\n326,691\n\n16,097,079\n\n \n\nThe compensation of our named executive officers therefore was approved by the requisite vote of our stockholders, on an advisory basis.\n \n\nNo other proposals were submitted to a vote of our stockholders at the annual meeting.\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nAmerican Healthcare REIT, Inc.\n\n \n\n \n\n \n\n \n\nDate:\n\nJune 25, 2026\n\nBy:\n\n/s/ Jeffrey T. Hanson\n\n \n\n \n\n \n\nName: Jeffrey T. Hanson\nTitle: Interim Chief Executive Officer and President"}